Loading
institutionsInstitution
ICMR-National Institute of Cancer Prevention and Research
ICMR's cancer prevention institute near Delhi, focused on the cancers India can prevent: cervical cancer through HPV screening and vaccination, and oral cancer through tobacco control.
Also called: NICPRInstitute of Cytology and Preventive OncologyICPO
Overview
The institute began as the Institute of Cytology and Preventive Oncology and was renamed the National Institute of Cancer Prevention and Research; it sits in Noida on the edge of Delhi and, in ICMR's words, conducts basic, clinical and applied research on the common cancers prevalent in India. Its work centres on cervical cancer screening (cytology and HPV testing), HPV vaccination studies, oral cancer and smokeless tobacco, including a WHO Framework Convention on Tobacco Control knowledge hub on smokeless tobacco, and training of health workers for the national screening programme for oral, breast and cervical cancer.
Location
Noida, IN
Type
research institute
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#229 · 26 points (0 Newsweek + 0 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to National Institute of Cancer Prevention and Research, including child institutions. 33 works · 1,173 citations · 76% open access · 6% clinical trials · 3% reviews.
Oncology works per year
72022
52023
82024
92025
42026
Most works
- Showket Hussain8 works
- Roopa Hariprasad4 works
- Kavitha Dhanasekaran3 works
- Subhash Mohan Agarwal2 works
- Tanvir Kaur2 works
- Smita Asthana2 works
- Asiya Khan2 works
- Pranay Tanwar2 works
- Sandeep Sisodiya2 works
- Agneesh Pratim Das2 works
Most cited
- Cervical cancer screening and HPV research
- Smokeless tobacco and oral cancer
- Screening training for health workers
Similar pages
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares International Agency for Research on Cancer (IARC / WHO), Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
- IdeaSwitch every country to single-dose HPV vaccination and add catch-up to age 26
Shares International Agency for Research on Cancer (IARC / WHO), Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
- PersonJade Goody
Shares HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed, The hardest cancers are found late.
- PersonAndré Ilbawi
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), HPV & HBV vaccination, Cervical cancer.
- IdeaCommunity-tailored HPV vaccine confidence campaigns with school-based delivery
Shares Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed, Cervical cancer.
- Key paperHPV screening for cervical cancer in rural India (Osmanabad)
Shares HPV DNA testing and self-sampling, International Agency for Research on Cancer (IARC / WHO), Prevention we already have is not deployed, The hardest cancers are found late.
- Key paperEffect of screening on oral cancer mortality in Kerala, India
Shares Chemoprevention & risk-reducing surgery, International Agency for Research on Cancer (IARC / WHO), Prevention we already have is not deployed, The hardest cancers are found late.
- TrialOsmanabad cervical screening trial (HPV testing vs cytology vs VIA)
Shares HPV DNA testing and self-sampling, International Agency for Research on Cancer (IARC / WHO), Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, Prevention we already have is not deployed.